Top India Stocks For 2014

Independent oil and gas firm Anadarko Petroleum Corp. (NYSE: APC)�on Sunday announced the sale of a 10% stake in a natural gas development block offshore of Mozambique to India�� state-controlled energy company ONGC Videsh for $2.64 billion in cash. Anadarko now owns 26.5% working interest in the project and is the operator.

The most interesting thing about this transaction is what Anadarko plans to do with the cash it gets from ONGC. The company said it plans to use the proceeds from the sale to ��ccelerate��development in its U.S. shale oil and liquids plays.

Anadarko is building its cash hoard, which totaled nearly $4.6 billion at the end of June, in order to develop its liquids plays in the United States. We noted last week in our report on companies spending the most to find oil that Anadarko plans to spend $5.5 billion this year to boost its U.S. oil production. This asset sale should help accomplish that, as well as giving the company some room to raise its anemic 0.8% dividend yield.

Hot Retail Stocks For 2015: Dr. Reddy's Laboratories Ltd(RDY)

Dr. Reddy?s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec Internatio nal for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddy?s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

Advisors' Opinion:

• [By Ben Levisohn]

  Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.

Top India Stocks For 2014: Sify Technologies Limited(SIFY)

Sify Technologies Limited provides enterprise and consumer Internet services primarily in India. The company offers various corporate network/data services comprising e-commerce and network connectivity solutions, such as end-to-end services network, application, and security services; voice origination and termination services; co-location and managed hosting services; and system integration services for data centre build, hardware distribution, security solutions, and turnkey projects. It also provides application services, including SLEMS and Microsoft Exchange messaging platforms; I-test for online assessment and LiveWire, which enable management of training processes across the organization; document management system for the management of documents electronically; and Forum, a forward supply chain solution. In addition, the company operates e-Ports that offer browsing, chat, email, gaming, utility bill payment, travel ticketing, hotel booking, mobile recharge, Intern et telephony, and online share trading services; and portals, which provide news, views, reviews, interactions, and services in the areas of movies, sports, finance, food, videos, astrology, online games, shopping, and travel, as well as offers content offerings and broadband services. Further, it provides infrastructure management services, such as network management, datacenter and helpdesk outsourcing, desktop and storage outsourcing, IT security outsourcing, LAN and WAN outsourcing, database and telecom outsourcing, and application monitoring and management services to automotive, chemical, media, and financial enterprises; and virtualization design, integration, and deployment services for servers, storage, networks, and end user clients. Sify has approximately 1,278 e-Ports in 200 towns and cities; and serves 1,06,000 broadband subscribers through 1500 cable TV Operators. The company, formerly known as Sify Limited, was founded in 1995 and is based in Chennai, India. Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY).

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY). Utilities shares dropped by 0.11 percent in the US market today.

Top India Stocks For 2014: Stewart Information Services Corporation(STC)

Stewart Information Services Corporation provides title insurance and related information services required for settlement by the real estate and mortgage industries. It operates in two segments, Title Insurance-Related Services and Real Estate Information. The Title Insurance-Related Services segment offers services that include searching for and examining documents, such as deeds, mortgages, wills, divorce decrees, court judgments, liens, paving assessments, and tax records, as well as provides titles insurance for residential and commercial properties, undeveloped acreage, farms, ranches, and water rights. This segment serves attorneys, builders, developers, home buyers and home sellers, lenders, and real estate brokers. The Real Estate Information segment offers products and services, which primarily include lender services, title technology, foreign and domestic government services, mapping, title information, Internal Revenue Code Section 1031 tax-deferred property e xchanges, pre-employment services, and online filing and transaction management. Its customers include mortgage lenders and servicers, mortgage brokers, mortgage investors, government entities, commercial and residential real estate agents, land developers, builders, title insurance agencies, and others interested in obtaining property information, as well as accountants, attorneys, investors, and employers. The company has operations primarily in the United States, Canada, the United Kingdom, central Europe, Mexico, central America, and Australia. Stewart Information Services Corporation was founded in 1893 and is based in Houston, Texas.

Advisors' Opinion:

• [By Ben Levisohn]

  Tower Group has dropped 40% to $4.43 today, and some other small insurers are also getting dinged this morning. HCI Group (HCI) has fallen 1.8% to $39.36, Stewart Information Services (STC) has declined 0.7% to $31.36 and the Navigators Group (NAVG) has ticked down 0.4% to $56.10.

Top India Stocks For 2014: Infosys Technologies Limited(INFY)

Infosys Ltd. provides information technology (IT) and consulting services worldwide. It offers IT services, such as application, architecture, independent validation and testing, information management, infrastructure, packaged application, SOA, systems integration, and knowledge services; product engineering services, manufacturing process and plant solutions, and product lifecycle management services; and consulting services in the areas of information and technology strategies, product innovation, next generation commerce, process excellence, and learning and complex change. The company also provides business process outsourcing solutions in the areas of business platforms, customer service outsourcing, finance and accounting, human resources outsourcing, legal services, sales and fulfillment, and sourcing and procurement outsourcing. In addition, it offers collaborative analytics solutions; digital consumer platform; Finacle universal banking solution; iProwe, a Web ac cessibility assessment product; mConnect, a real-time enterprise middleware; and research and analytical support services. Further, the company offers unified communications and collaboration solution that streamlines business processes between employees, customers, and suppliers; iTransform that helps healthcare organizations accelerate transition to new platforms; and supply chain visibility and collaboration product suite. It serves aerospace and defense, airlines, automotive, banking, capital markets, communication services, consumer packaged goods, manufacturing, education, energy, healthcare, high technology, hospitality and leisure, insurance, life sciences, logistics and distribution, publishing, resources, utilities, and retail industries. Infosys Ltd. has a strategic partnership with Alstom SA. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Ltd. on June 16, 2011. Infosys Ltd. was founded in 1981 and is headquartered i n Bengaluru, India.

Advisors' Opinion:

• [By Brian Stoffel]

  That helps explain why Accenture and IBM,�the industry's two biggest players, have been able to gobble up so much market share. But there's a second tier of technology-consultants -- in terms of sheer size -- as well. That's where Cognizant, as well as its main competition --�Infosys (NYSE: INFY  ) and Wipro (NYSE: WIT  ) �-- come in to play.

• [By Robert Martin]

  Infosys (INFY), Housing Development Finance and Reliance Industries LTD are the top three holdings, with weightings between 8% and 10.5%. Of course, just about any India ETF will have a heavy� allocation to Infosys and Reliance. However, INDA dedicates a lower percentage to energy than some of the alternatives, and instead leans more on IT and consumer spending.

Best Specialty Retail Stocks To Buy For 2014

Popular Posts: 10 Oil and Gas Stocks to Buy Now15 Oil and Gas Stocks to Sell NowBiggest Movers in Energy Stocks Now – NGLS EXXI WTI TPLM Recent Posts: Biggest Movers in Healthcare Stocks Now – PBYI AGN PRGO EXAS Biggest Movers in Basic Materials Stocks Now – BCPC KS CMP WOR Hottest Technology Stocks Now – SUNE MLNX NSIT BRCD View All Posts 4 Specialty Retail Stocks to Buy Now

The grades of four specialty retail stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

Best Japanese Stocks To Invest In Right Now: Sa Sa International Holdings Ltd (SAXJF)

Sa Sa International Holdings Limited is an investment holding company. The Company�� subsidiaries are principally engaged in the retailing and wholesaling of cosmetic products. Its business covers Hong Kong and Macau, Mainland China, Taiwan, Singapore, and Malaysia. The Company operates in two segments: retail segment, engaged in the operation of cosmetics specialty stores, which offer a variety of products from over 600 beauty brands, covering a wide of products from skin care, fragrance, make-up, body care and hair care to health foods, and brand management segment, engaged in the management of over 100 beauty brands. It also offers round-the-clock online shopping services along with product and corporate information through its e-commerce platform, sasa.com. The Company�� subsidiaries include Alibaster Management Limited, Base Sun Investment Limited, Cyber Colors Limited, Docile Company Limited and Elegance Trading (Shanghai) Company Limited, among others. Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  HONG KONG (MarketWatch) -- Hong Kong stocks swung between small gains and losses early Thursday after hitting a seven-month high in the previous session, with the Hang Seng Index (HK:HSI) down less than 0.1%. Most mainland Chinese property developers outperformed the markets, with Guangzhou R&F Properties Co. (HK:2777) (GZUHF) rallying 3.4%, after the company reported a 44% month-on-month jump in sales for June. Shimao Property Holdings Ltd. (HK:0813) (SIOPF) climbed 2.6%, and China Resources Land Ltd. (HK:1109) (CRBJF) rose 1.7%. However, several retailers were weak, as Want Want China Holdings Ltd. (HK:0151) (WWNTF) , the country's top food and beverage maker, declined 2%. Hong Kong-based cosmetics brand Sa Sa International Holdings (HK:0178) (SAXJF) fell 1.6%, with a decline in Chinese June non-manufacturing data helping weigh on some retailers. Over on the Chinese mainland, the Shanghai Composite Index (CN:SHCOMP) retreated 0.4%, pulling back from its highest close in two weeks.

Best Specialty Retail Stocks To Buy For 2014: CSS Industries Inc (CSS)

CSS Industries, Inc. (CSS), incorporated on November 5, 1923, is a company primarily engaged in the design, manufacture, procurement, distribution and sale of seasonal and all occasion social expression products, principally to mass market retailers. These seasonal and all occasion products include gift wrap, gift bags, gift boxes, gift card holders, boxed greeting cards, gift tags, decorative tissue paper, decorations, classroom exchange Valentines, decorative ribbons and bows, floral accessories, Halloween masks, costumes, make-up and novelties, Easter egg dyes and novelties, craft and educational products, stickers, memory books, stationery, journals, notecards, infant and wedding photo albums, scrapbooks, and other gift items that commemorate life�� celebrations. In September 5, 2012, it sold the Halloween portion of its Paper Magic business to Gemmy Industries (HK) Limited.

CSS��product provides its retail customers the opportunity to use a single vendor for much of their seasonal product requirements. A substantial portion of CSS��products are manufactured, packaged and/or warehoused in 10 facilities located in the United States, with the remainder purchased primarily from manufacturers in Asia and Mexico. The Company�� products are sold to its customers by national and regional account sales managers, sales representatives, product specialists and by a network of independent manufacturers��representatives. The Company�� principal operating subsidiaries include Paper Magic Group, Inc. (Paper Magic), Berwick Offray LLC (Berwick Offray) and C.R. Gibson, LLC (C.R. Gibson). CSS designs, manufactures, procures, distributes and sells a range of seasonal consumer products primarily through the mass market distribution channel. Christmas products include gift wrap, gift bags, gift boxes, gift card holders, boxed greeting cards, gift tags, decorative tissue paper and decorations. CSS��Valentine product offerings include classroom exchange Valentine cards and other related Valen! tine products, while its Easter product offerings include Dudley�� brand of Easter egg dyes and related Easter seasonal products. CSS also designs and markets decorative ribbons and bows, all occasion boxed greeting cards, gift wrap, gift bags, gift boxes, gift card holders, decorative and waxed tissue, decorative films and foils, stickers, memory books, stationery, journals, notecards, infant and wedding photo albums, scrapbooks, floral accessories and other gift and craft items to its mass market, craft, specialty and floral retail and wholesale distribution customers, and teachers' aids and other learning oriented products to the education market through mass market retailers, school supply distributors and teachers' stores. Key brands include Paper Magic, Berwick, Offray, C.R. Gibson, Markings, Creative Papers, Tapestry, Dudley��, Don Post Studios, Eureka, Learning Playground, Stickerfitti and iota. Key brands include Paper Magic, Berwick, Offray, C.R. Gibson, Markings, Creative Papers, Tapestry, Seastone, Dudley��, Eureka, Learning Playground and Stickerfitti.

CSS operates 10 manufacturing and/or distribution facilities located in Pennsylvania, Maryland, New Hampshire, South Carolina, Alabama and Texas. Its boxed greeting cards are produced by Asian manufacturers to the Company�� specifications. Halloween make-up and Easter egg dye products are manufactured in Asia to specific formulae by contract manufacturers who meet regulatory requirements for the formularization and packaging of such products. Ribbons and bows are primarily manufactured and warehoused in seven facilities located in Pennsylvania, Maryland, South Carolina and Texas. Memory books, stationery, journals and notecards, infant and wedding photo albums, scrapbooks, and other gift items are imported from Asian manufacturers and warehoused and distributed from a distribution facility in Florence, Alabama. Floral accessories, including pot covers, foil, waxed tissue, shred, aisle runners, corsage bags and other paper! and film! products, are manufactured in a facility located in Milford, New Hampshire and Juarez, Mexico. Manufacturing includes gravure and flexo printing, waxing and converting. Products are warehoused and distributed from a distribution facility in Berwick, Pennsylvania. Other products including, but not limited to, decorative tissue paper, all occasion gift wrap, gift tags, gift bags, gift boxes, gift card holders, classroom exchange Valentine products, Halloween masks, costumes and novelties, Easter products, decorations and school products are designed to the specifications of CSS and are imported primarily from Asian manufacturers.

Advisors' Opinion:

• [By Rich Duprey]

  Gifts maker�CSS Industries� (NYSE: CSS  ) �announced yesterday its second-quarter dividend of $0.15 per share, the same rate it's paid since 2008.

Best Specialty Retail Stocks To Buy For 2014: Puget Technologies Inc (PUGE)

PUGET TECHNOLOGIES, INC., incorporated on March 17, 2010, is a development-stage company. The Company is engaged in the distribution of luxury wool bedding sets produced in Germany. The Company�� product includes Lama Wool, Camel Wool, Cashmere Wool and Merino Wool.

The Company�� Lama Wool is consists of 50% Lama Wool hair, and 50% Merino wool hair. The Camel wool is consists of 50% Camel wool hair, and 50% Merino wool hair. The Cashmere wool is blended with Merino wool.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Inscor, Inc (OTCMKTS: IOGA), Puget Technologies Inc (OTCBB: PUGE) and PTA Holdings Inc (OTCMKTS: PTAH) have all been getting some attention lately in various investment newsletters or investor alerts. However, two of these small caps have been the subject of paid promotions while the third is getting attention largely because its in the growing marijuana or cannabis business. With that in mind, are these stocks really all that hot or not? Here is a quick reality check:

Best Specialty Retail Stocks To Buy For 2014: Barnes & Noble Inc (BKS)

Barnes & Noble, Inc. (Barnes & Noble), incorporated on November 19, 1986, is a bookseller. The Company is a content, commerce and technology company that provides customers access to books, magazines, newspapers and other content across its multi-channel distribution platform. As of April 27, 2013, it operated 1,361 bookstores in 50 states, 686 bookstores on college campuses, and operates one of the Web eCommerce sites, and develops digital content products and software. Barnes & Noble operates in three segments: B&N Retail, B&N College and NOOK. The Company�� principal business is the sale of trade books (generally hardcover and paperback consumer titles), mass market paperbacks (such as mystery, romance, science fiction and other popular fiction), children�� books, eBooks and other digital content, NOOK and related accessories, bargain books, magazines, gifts, cafe products and services, educational toys & games, music and movies direct to customers through its bookstores or on barnesandnoble.com.

Of the Company�� 1,361 bookstores, 675 operate primarily under the Barnes & Noble Booksellers trade name. Barnes & Noble College Booksellers, LLC (B&N College), a wholly owned subsidiary of Barnes & Noble, operates 686 college bookstores at colleges and universities across the United States. Barnes & Noble Retail (B&N Retail) operates the 675 retail bookstores. Retail also includes the Company�� eCommerce site and Sterling Publishing Co., Inc. (Sterling or Sterling Publishing), a leader in general trade book publishing.

B&N Retail

This segment includes 675 bookstores as of April 27, 2013, primarily under the Barnes & Noble Booksellers trade name. These stores generally offer a dedicated NOOK area, a comprehensive trade book title base, a cafe, and departments dedicated to Juvenile, Toys & Games, DVDs, Music, Gift, Magazine and Bargain products. The stores also offer a calendar of ongoing events, including author appearances and children�� activities. The B&! N Retail segment also includes the Company�� eCommerce website, barnesandnoble.com, and its publishing operation, Sterling Publishing. Barnes & Noble stores range in size from 3,000 to 60,000 square feet depending upon market size, with an overall average store size of 26,000 square feet. During the fiscal year ended April 27, 2013 (fiscal), the Company reduced the Barnes & Noble store base by 0.3 million square feet, bringing the total square footage to 17.7 million square feet. The Company�� B&N Retail segment purchases physical books on a regular basis from over 800 publishers and over 50 wholesalers or distributors. As of April 27, 2013, Barnes & Noble had stores in 162 of the total 210 Designated Market Area markets.

Sterling Publishing is a publisher of non-fiction trade titles. It is a range of non-fiction and illustrated books and kits across a range of imprints, in categories, such as health and wellness, music and culture, food and wine, crafts and photography, puzzles and games, history and current affairs, as well as a children�� books.

B&N College

B&N College sells new and used textbooks in campus bookstores and online. As of April 27, 2013, B&N College operated 686 stores nationwide. The Company�� customer base, which is mainly consisted of students and faculty, can purchase various items from their campus stores, including textbooks and course-related materials, emblematic apparel and gifts, trade books, computer products, NOOK products and related accessories, school and dorm supplies, convenience and cafe items.

As of April 27, 2013, B&N College operates 651 traditional college bookstores and 35 academic superstores, which are generally larger in size, offer cafes and provide a sense of community that engages the surrounding campus and local communities in college activities and culture. The traditional bookstores range in size from 500 to 48,000 square feet. The academic superstores range in size from 8,000 to 75,000 square feet. B&! N College! �� three customer constituencies are students, faculty members and campus administrators.

NOOK

This segment includes the Company�� digital business, which includes the Company�� eBookstore, digital newsstand and sales of NOOK devices and accessories to third party distribution partners, as well as to B&N Retail and B&N College. Barnes & Noble�� NOOK digital bookstore and Reading Apps provide customers the ability to purchase and read their digital content and access to their Lifetime Library on a range of digital platforms, including Windows 8 PCs and tablets, iPad, iPhone , Android smartphones and tablets, PC and Mac. Barnes & Noble has implemented features on its digital platform to ensure that customers can access their NOOK content from almost all of today�� most popular devices.

The Company competes with Target, Books-A-Million, Waldenbooks, Amazon.com, Apple, Wal-Mart and Costco.

Advisors' Opinion:

• [By Teresa Rivas]

  Shares of Barnes & Noble (BKS) were falling before the close Thursday, on news that John Malone�� Liberty Media (LMCA) is selling most of its 17% stake in the bookseller.

  Liberty Media reached an agreement with Barnes & Noble to sell 90% holdings, which will result in the loss of one of its two board seats. The shares are being purchased by institutional investors, with the sale expected to close next week.

  As The Wall Street Journal reports, Liberty didn�� say how much it was selling the share for, but the move comes after Barnes & Noble has enjoyed a big rally, climbing 66% since February through yesterday�� close. A person close to the deal says that the price was higher than $250 million, which would give Liberty a good deal of profit, as it paid $204 million for the entire stake in 2011. It�� also been earning a fixed dividend on the preferred shares: The anonymous source pegs a return of more than20% on the investment.

  Read Barron�� take on the stock from last month here.

Best Specialty Retail Stocks To Buy For 2014: Ulta Salon Cosmetics and Fragrance Inc (ULTA)

Ulta Salon, Cosmetics & Fragrance, Inc. (Ulta), incorporated on January 9, 1990, is a beauty retailer, which provides one-stop shopping for prestige, mass and salon products and salon services in the United States. During the year ended January 28, 2012 (fiscal 2011), the Company opened 61 new stores. It operates full-service salons in all of its stores. Its Ulta store format includes an open and modern salon area with approximately eight to 10 stations. The entire salon area is approximately 950 square feet with a concierge desk, skin treatment room, semi-private shampoo and hair color processing areas. Each salon is a full-service salon offering hair cuts, hair coloring and permanent texture, with salons also providing facials and waxing.

The Company offers products in the categories, such as cosmetics, which includes products for the face, eyes, cheeks, lips and nails; haircare, which includes shampoos, conditioners, styling products, and hair accessories; salon styling tools, which includes hair dryers, curling irons and flat irons; skincare and bath and body, which includes products for the face, hands and body; fragrance for both men and women; private label, consisting of Ulta branded cosmetics, skincare, bath and body products and haircare, and other, including candles, home fragrance products and other miscellaneous health and beauty products. The Company has combined its three operating segments: retail stores, salon services and e-commerce, into one reportable segment.

The Company competes with Macy��, Nordstrom, Sephora, Bath & Body Works, CVS/pharmacy, Walgreens, Target, Wal-Mart, Regis Corp., Sally Beauty and JCPenney salons.

Advisors' Opinion:

• [By Dan Caplinger]

  On Tuesday, Ulta Salon, Cosmetics & Fragrance (NASDAQ: ULTA  ) will release its quarterly report, and shareholders haven't been able to recover from steep losses toward the end of 2013. But with department-store retailers Macy's (NYSE: M  ) and Nordstrom (NYSE: JWN  ) working hard to capture their own share of the beauty market, Ulta Salon will have to work even harder to woo customers into its doors and make the most of the opportunity once they arrive.

Get used to market volatility

The CBOE Volatility Index, or the VIX, has ticked up in recent weeks as the economic picture becomes uncertain.

NEW YORK (CNNMoney) Buckle up investors, it looks like it's going to be a bumpy ride for stocks for the foreseeable future.

Big swings in the market have been a common theme already this year.

The CBOE Volatility Index (VIX), or VIX, is up nearly 15% so far in 2014. And CNNMoney's Fear and Greed Index, which tracks the VIX and six other gauges of investor sentiment, has been in Extreme Fear mode for more than a week. It may stay like this for a while.

"There's probably going to be a lot of up and downs in the next few months," said Anthony Valeri, an investment strategist with LPL Financial.

That's because investors are trying to get a sense of where the economy actually stands, said Brad McMillan of Commonwealth Financial Network. Weaker than-expected economic reports, including two straight months of tepid jobs growth, are upending the notion that the economy is picking up steam, he said.

And while unseasonably cold weather may be to blame, investors can't know for certain.

Then there's the Federal Reserve.

The central bank announced in December that it would start scaling back, or tapering, the size of its monthly bond purchases. The main reason for this was that the Fed felt that the recovery was sustaining momentum. But it's no longer a slam dunk that the Fed will taper again at its next meeting in March.

Turmoil in the emerging markets is only adding to the confusion for investors.

So how can investors protect themselves, or even profit from, these big swings?

Valeri urges investors to buy on the dips. "When you see these bouts of volatility, you should treat them as a buying opportunity," he said.

But McMillan sees it differently. His advice: sit tight.

"If you have a multi-year time frame, this is noise," he said. "More money has been lost trying to time the market than with market fluctuations."

There are also financial products designed to do well when the market goes haywire, but they're not for the faint of heart.

Todd Salamone of Schaeffers Research, an options trading advisory firm, encourages investors to study the ups and downs of individual stoc! ks rather than look at the overall market.

  High speed trading showdown

Options, which are contracts that give investors the right to buy or sell a stock at a specific price on or by a set date, typically thrive off volatility. For example, the price of certain kinds of options for companies that are rumored takeover targets will often spike well before the stock price moves.

Traditionally reserved for big time Wall Street players, options are now offered to individual investors by leading online brokers such as Charles Schwab (SCHW, Fortune 500), E*Trade (ETFC), and TD Ameritrade (AMTD).

But option trading is risky business, and definitely not for everyone. Large investment firms often use them to hedge their bets.

The most important thing: "know what you're buying, understand how it works," Salamone said.

Another tool: exchange-traded funds designed to perform well in times of volatility.

The CBOE Emerging Markets ETF Volatility (VXEEM), for example, tracks volatility in emerging markets companies. It's up more than 20% so far this year due to worries about the health of the so-called "Fragile Five" emerging markets.

But again, caution is urged before delving in, as investors can lose a lot of money should the markets smooth out and go about their regular business. To that end, this ETF plunged 7% on Thursday when the broader market rallied. And it fell another 3% Friday as stocks rose again.

So Valeri only recommends volatility ETFs for very aggressive investors.

IRA Rollovers Among Hot Areas for FINRA Scrutiny in 2014

The Financial Industry Regulatory Authority warned broker-dealers Thursday to prepare for heightened scrutiny this year in a host of areas, namely of their recommendations on IRA rollovers, private placements and complex products like nontraded REITs.

FINRA highlights in its exam priorities letter that it will also create this year a dedicated enforcement team under its High Risk Broker initiative to prosecute brokers who have a pattern of sales practice abuses. FINRA barred 16 such brokers in 2013.

Susan Axelrod, FINRA’s executive vice president of regulatory operations, encouraged firms to use the guidance “along with their own analysis” to enhance their compliance programs as FINRA “will be examining for strong controls and robust compliance efforts in these areas.”

Richard Ketchum, FINRA’s chairman and CEO, said in the same statement that by providing “detailed guidance to firms, we hope to not only support firms’ compliance efforts but also to alert firms to the issues we have identified as the most salient risks to investors and the integrity of our markets.”

FINRA notes that its areas of concern include conflicts of interest, fraud, how firms handle liquidity risk, and high-frequency and algorithmic trading, and that the self-regulator “will update its view on risks throughout the year.”

10 Best Dow Dividend Stocks To Invest In 2015

Cipperman Compliance Services notes that while FINRA’s exam priorities letter helps firms by highlighting FINRA’s new focus areas (interest-rate sensitive securities, recidivist brokers), “every year the list just gets longer because FINRA never really drops any of the old topics off the list (for example, anti-money laundering, customer data protection, conflicts of interest).”

Products to Watch

FINRA says that it will examine the suitability of recommendations to retail investors for complex products, which include structured products, like leveraged exchange-traded funds; interest-rate sensitive investments, like long-duration bond funds and muni securities; nontraded real estate investment trusts; frontier emerging-market funds; and mortgage-backed securities.

Qualified Plan Rollovers

FINRA also says that in 2014, reviewing firms’ qualified plan rollover practices will be an examination priority, and that staff will examine firms’ marketing materials and supervision in this area. FINRA will also evaluate securities recommendations made in rollover scenarios to determine whether they comply with suitability standards in FINRA Rule 2111.

In its just released Regulatory Notice 13-45, FINRA reminds firms of their responsibilities concerning IRA rollovers. FINRA said that it issued the December notice to remind firms of their responsibilities when recommending a rollover or transfer of assets in an employer-sponsored retirement plan to an IRA or marketing IRAs and associated services.

FINRA says that it shares the Government Accountability Office’s concerns that investors may be misled about the benefits of rolling over assets from a 401(k) plan to an IRA. In Regulatory Notice 13-23, FINRA warned against making claims of “free IRAs” or “no-fee IRAs” where investors do pay costs associated with these accounts.

Private Placements

FINRA says that it will not only be monitoring general solicitation and advertising of private placements under the recently adopted amendments to Rule 506 of Regulation D, but it will also assess the due diligence suitability of private placements. The self-regulator will also focus on offerings of securities through private placements. /* .premium-promo { border: 1px solid #ddd; padding: 10px; margin: 0 10px 10px 0; width: 200px; float: left; } .premium-promo li, .premium-promo ul { list-style-type: none; margin: 0; padding: 0; } .premium-promo li { margin: 0 0 10px; padding: 0 0 10px; border-bottom: 1px dotted #ddd; } .premium-promo h3 { text-transform: uppercase; font-size: 11px; } .premium-promo h4 { font-size: 16px; } .premium-promo a { text-decoration: none !important; } .premium-promo .btn { background: #0069a1; border-radius: 4px; display: inline-block; padding: 5px 10px; clear: both; color: #fff; font-weight: bold; } .premium-promo .btn:hover { background: #034c92; } */ Crowdfunding Portals

As part of the JOBS Act, which became law in 2012, retail investors will be allow to purchase unregistered securities offered through crowdfunding websites. However, to maintain investor protections, the Act limits the amount they can invest in a year based on their income and net worth. The SEC and FINRA proposed rules on Oct. 23, and comments are due by Feb. 3.

FINRA notes that the objective of its proposed rules is to ensure that the capital-raising objectives of the JOBS Act are advanced in a manner consistent with investor protection.

Until adoption of the SEC’s proposed rules, no JOBS Act crowdfunding is lawful.

FINRA notes that as its rules become effective, and funding portals become FINRA members, the self-regulator will implement a regulatory program designed to protect investors while recognizing the distinctions between funding portals and broker-dealers.

---

Check out these related stories on ThinkAdvisor:

 

10 Best Cheap Stocks To Invest In 2014

Duncan Selby/AlamyDon't forget to budget for the travel and hobbies you will finally have time for in retirement. Most people accept that retirement won't be cheap. But just how expensive will it be? Visions of the ideal retirement range from the extravagant pursuit of everything we have dreamed of to frugal plans calculated to stretch the buying power of our hard earned savings. Whatever course we set, we need to accurately estimate and budget for our future. While the final tab will vary depending on your lifestyle, some expenses are shared across-the-board and need to be budgeted for.

Hot Diversified Bank Companies To Watch In Right Now: Capstone Turbine Corporation(CPST)

Capstone Turbine Corporation develops, manufactures, markets, and services turbine generator sets and related parts for use in stationary distributed power generation applications. Its stationary distributed power generation applications include cogeneration combined heat and power (CHP), integrated (CHP), resource recovery, and secure power, as well as combined cooling, heat, and power; and its products are used as battery charging generators for hybrid electric vehicle applications. The company primarily offers microturbine units, subassemblies, and components. It also provides various accessories, including rotary gas compressors with digital controls, heat recovery modules for CHP applications, dual mode controllers that allow automatic transition between grid connect and stand-alone modes, batteries with digital controls for stand-alone/dual-mode operations, power servers for multipacked installations, and protocol converters for Internet access, as well as frames, ex haust ducting, and installation hardware. Further, it remanufactures microturbine engines; and provides after-market parts and services, scheduled and unscheduled maintenance, and factory and on-site training services. The company?s microturbines can be fueled by various sources, including natural gas, propane, sour gas, landfill or digester gas, kerosene, diesel, and biodiesel. It primarily sells its products directly to end users, as well as through distributors in North America, Asia, Australia, Europe, the Russian Federation, and South America. Capstone Turbine Corporation was founded in 1988 and is based in Chatsworth, California.

Advisors' Opinion:

• [By Dan Caplinger]

  Beyond the fundamentals, though, news plays an important role in short-term stock movements. Outside the Dow, microturbine producer Capstone Turbine (NASDAQ: CPST  ) soared 8.8% after receiving its second large order in the past week. After getting word of a purchase from real-estate and investment firm Related Companies on Tuesday, Capstone got an order today from Southern California Gas to buy three of its C65 uninterruptible power-source units for use at the gas company's data center. Given the relatively small size of the business, which sports sales of only about $122 million over the past year, orders like this have a material effect on Capstone and also draw the attention of other prospective buyers.

10 Best Cheap Stocks To Invest In 2014: Oracle Corporation(ORCL)

Oracle Corporation, an enterprise software company, develops, manufactures, markets, distributes, and services database and middleware software, applications software, and hardware systems worldwide. It licenses of database and middleware software, including database management software, application server software, service-oriented architecture and business process management software, data integration software, business intelligence software, identity and access management software, content management software, portals and user interaction software, development tools, and Java; and applications software comprising enterprise resource planning, customer relationship management, enterprise performance management, supply chain management, business intelligence applications, enterprise portfolio project management, Web commerce, and industry-specific applications software. The company also offers customers with rights to unspecified software product upgrades and maintenance releases; Internet access to technical content; and Internet and telephone access to technical support personnel. In addition, its hardware systems products consist of computer server and hardware-related software, including the Oracle Solaris Operating System; and storage products, such as tape, disk and networking solutions for open systems and mainframe server environments. Its hardware systems support solutions include software updates for the software components. Further, the company offers consulting solutions in business and IT strategy alignment, enterprise architecture planning and design, initial product implementation and integration, and ongoing product enhancements and upgrades; cloud services, including Oracle Cloud Services and Advanced Customer Services; and education solutions comprising instructor-led, media-based, and Internet-based training in the use of its software and hardware products. The company was founded in 1977 and is headquartered in Redwood Ci ty, California.

Advisors' Opinion:

• [By Anders Bylund]

  This quarter was a though slough for most enterprise IT specialists. Oracle (NYSE: ORCL  ) disappointed in its latest report, citing poor sales execution against a difficult macroeconomic backdrop. IBM (NYSE: IBM  ) followed suit, blaming its unusual miss on soft government orders and a "once-every-10-year event" in China. Both stocks plunged after reporting results, 8% in IBM's case and more than 10% for Oracle.

• [By Mani]

  Cloud is the future and critical for most tech giants. Oracle Corporation (NYSE:ORCL) is no exception.

  Oracle now generates more than $1 billion of subscription revenues annually from its cloud-hosted application suite, equal to about 3 percent of total revenues and 11 percent of total software license and subscription revenues.

• [By WALLSTCHEATSHEET]

  Oracle is an international supplier of software and hardware products and services to companies operating in various industries. The company investors partied a day after the database giant released its fiscal second quarter earnings showing big gains for cloud services and some high-end hardware. The stock has been quietly trending higher and is currently trading near all time highs. Over the last four quarters, earnings and revenues have been rising, which has left investors pleased. Relative to its peers and sector, Oracle has been a relative performance leader year-to-date. Look for Oracle to OUTPERFORM.

10 Best Cheap Stocks To Invest In 2014: Merck & Company Inc.(MRK)

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company?s Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, diabetes and obesity, infectious diseases, neurosciences and ophthalmology, oncology, vaccines, and women's health and endocrine. This segment also offers human health vaccines, such as preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products. This segment offers antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fish. The Consumer Care segment develops, manufac tures, and markets over-the-counter, foot care, and sun care products. Its over-the-counter product line includes non-drowsy antihistamines; treatment for occasional constipation; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and treatment for frequent heartburn. This segment?s foot care products comprise topical antifungal, and foot and sneaker odor/wetness products; and sun care products include sun care lotions, sprays and dry oils; and sunburn relief products. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, and managed health care providers, as well as food chain and mass merchandiser outlets in the United States and Canada. Merck & Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

Advisors' Opinion:

• [By JulieYoung789]

  In the DJIA financial stocks Visa (V) and Goldman Sachs led the index higher. Visa was up 1.86% ending at $221.03 and Goldman Sachs was up 1.33% ending the day at $167. Laggers in the index included Merck (MRK) which was down 0.44% to $58.18 and Wal-Mart (WMT) which was down 0.35% to $76.55.

• [By WWW.DAILYFINANCE.COM]

  Stallergenes/APOralair, a grass pollen tablet, is among a new generation of allergy treatments. TRENTON, N.J. -- For decades, seasonal allergy sufferers had two therapy options to ease the misery of hay fever. They could swallow pills or squirt nasal sprays every day for brief reprieves from the sneezing and itchy eyes. Or they could get allergy shots for years to gradually reduce their immune system's over-reaction. Now patients can try another type of therapy to train their immune system, new once-a-day tablets that dissolve quickly under the tongue and steadily raise tolerance to grass or ragweed pollen, much like the shots. "It's been several decades since the last big breakthrough," Cleveland Clinic allergy specialist Dr. Rachel Szekely said. The downside: The pills must be started a few months before the grass or ragweed pollen season. That means it's too late for people with grass allergies, but the time is now for ragweed allergy sufferers. The Food and Drug Administration in April approved two tablets from Merck, Grastek for grass pollen and Ragwitek for ragweed, plus a grass pollen tablet called Oralair from Stallergenes. The tablets could become popular with people who dislike pills that can make them drowsy or don't provide enough relief. They'll likely appeal even more to patients with severe allergies who fear needles or can't make frequent trips to the allergist, key reasons that only about 5 percent of U.S. patients who would benefit from allergy shots get them. Meanwhile, new treatments for other types of allergies, including to peanuts and eggs, are in various stages of testing and could turn out to be big advances. Drugmaker Merck & Co. (MRK) has a tablet for house dust mite allergies in final patient testing that could hit the market in two or three years, and it's considering other therapies. France's Stallergenes is testing a tablet for birch tree allergies and, with partner Shionogi & Co. in Japan, tablets for allergies

• [By Dan Carroll]

  That diabetes market isn't just attractive for market leader Novo; after all, rival Merck (NYSE: MRK  ) boasts one of the world's best drugs in blockbuster diabetes therapy Januvia that sold more than $5 billion last year. Merck has already seen the winds shift in China's direction: The company has opened three manufacturing plants in the nation already as of April, part of Merck's commitment in 2011 to invest $1.5 billion in China. Merck's a big and diversified enough company that other factors will influence its stock more in the short run -- particularly patent-related sales losses for blockbusters such as Singulair -- but in the long term, its China moves could pay off in a big way.

• [By Matt Thalman]

  Lastly, Pfizer (NYSE: PFE  ) is the biggest loser on the Dow today, though it has lost just 0.4%, while Merck (NYSE: MRK  ) is a hair below breakeven. Both pharmaceutical companies have performed alongside the market this year: Merck is up 16.56% year to date, and Pfizer has climbed 15.59%. But it hasn't been easy going. Both have seen massive losses in revenue and profit as patents have expired and generic companies have moved into the markets. Both have had some setbacks on developing drugs, though they've seen some promising signs from the research departments. But as my Foolish colleague Sean Williams noted earlier, Merck has a large short interest that seems to have grown over the past few weeks. Shareholders shouldn't worry about today's drops, as they come with very little news, but they need to focus on the long-term pipeline each company is developing and how the patent cliff will continue to effect each company.

10 Best Cheap Stocks To Invest In 2014: Lattice Semiconductor Corporation(LSCC)

Lattice Semiconductor Corporation designs, develops, manufactures, and markets programmable logic products and related software. The company offers field programmable gate array (FPGA) products, including LatticeECP family for deployment in wireless infrastructure and wireline access equipment, as well as in video and imaging applications; and LatticeXP for the security, surveillance, and display markets. It also provides programmable logic device (PLD) products comprising various versions of ispMACH4000 in-system programmable complex programmable logic device family; MachXO family that is designed for a range of low density applications; platform manager, power manager, and ispClock programmable mixed signal devices; and software development tools and intellectual property cores. The company sells its products directly to end customers through a network of independent manufacturers? representatives and indirectly through a network of independent sell-in and sell-through distributors. It primarily serves original equipment manufacturers in the communications, computing, consumer, industrial, military, automotive, and medical end markets. The company was founded in 1983 and is headquartered in Hillsboro, Oregon.

Advisors' Opinion:

• [By Lee Jackson]

  Lattice Semiconductor Corp. (NASDAQ: LSCC) is a top chip stock to buy at Jefferies. The company announced last month three new complete reference designs that will make it easier for electronic OEMs to deliver media-rich experiences to their end users by taking advantage of low-cost, industry-standard MIPI (Mobile Industry Processor Interface) camera, application processor and display technologies. The Jefferies price objective for the stock is $6.50, and the consensus is also at $6.50. Lattice closed yesterday at $4.63.

• [By kcpl]

  Lattice Semiconductor (LSCC) is doing well. It has seen improvements in its operations. The company excels in the manufacture of programmable chips which are sold in various segments such as mobile, communications, automotives, industrial etc. The reason for the company�� strong performance has been its key customers such as China Mobile and Cisco. On the back of a strong client base, Lattice has seen a good 40% growth in its stock price. Let us take a look at its business.

10 Best Cheap Stocks To Invest In 2014: Aegon NV(AEG)

AEGON N.V. provides life insurance, pensions, and asset management products and services worldwide. The company?s life insurance products include traditional, term, universal, whole, and other life insurance products sold as part of defined benefit pension plans, endowment policies, post-retirement annuity products, and group risk products; supplemental health insurance products comprise accidental death, other injury, critical illness, hospital indemnity, medicare supplement, and student health; specialty lines consists of travel, membership, and creditor products; and long term care insurance products for policyholders who require care due to a chronic illness or cognitive impairment. It also offers a range of savings and retirement products and services, including mutual funds, and fixed and variable annuities, savings accounts and investment contracts, segregated funds, guaranteed investment accounts, and single premium immediate annuities, as well as investment advice to individuals. In addition, the company offers employer solutions and pensions, such as retirement plans, pension plans, and pension-related products and services; investment products, including onshore and offshore bonds, and trusts; reinsurance products and solutions to life insurance and financial services companies; general insurance products comprising house, car, and fire insurance; and asset management products and services, including general account assets, unit-linked funds, and third party activities. AEGON N.V. markets its products through independent and career agents, financial planners, registered representatives, independent marketing organizations, banks, broker-dealers, benefit consulting firms, wirehouses, affinity groups, institutional partners, independent managing general agencies, and specialized financial advisors, as well as through online, direct, and worksite marketing. The company was founded in 1900 and is headquartered in The Hague, the Netherl ands.

Advisors' Opinion:

• [By Will Ashworth]

  Assuming it delivers on its outlook for 2014, its current free cash flow yield is a very enticing 20%. This isn�� a growth stock, but its brands still possess hidden value. As cheap stocks go, it�� very attractive.

  Cheap Stocks to Buy: Aegon (AEG)

  It�� not often that you can buy a $19 billion market cap for under 10 bucks. Aegon�� a Dutch insurance company that�� had a rough ride over the past few years, and its stock�� suffered as a result. In the late ’90s AEG stock traded around $60 — it hasn�� been anywhere close since. However, it�� got some good assets that should bear fruit in the years to come. Aegon has 12,000 employees in the Americas doing business primarily under the Transamerica brand, which has been a part of AEG since 1999.

10 Best Cheap Stocks To Invest In 2014: Wendy's/Arby's Group Inc.(WEN)

The Wendy's Company operates as a quick-service hamburger company in the United States. The company, through its subsidiary, Wendy's International, Inc., operates as a franchisor of the Wendy's restaurant system. As of December 26, 2011, the Wendy's system comprised approximately 6,500 franchise and company restaurants in the United States and the United States territories, as well as in 26 other countries worldwide. The company was formerly known as Wendy's/Arby's Group, Inc. and changed its name to The Wendy's Company in July 2011. The Wendy's Company was founded in 1884 and is headquartered in Dublin, Ohio.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 stock that's starting to move within range of triggering a major breakout trade is Wendy's (WEN), which operates quick-service restaurants specializing in hamburger sandwiches throughout the U.S. This stock has been on fire so far in 2013, with shares up sharply by 57%.

  If you take a look at the chart for Wendy's, you'll notice that this stock has been trending sideways and consolidating for the last two months, with shares moving between $8.11 on the downside and $8.88 on the upside. This consolidation has been occurring just above WEN's 50-day moving average of $8.23 a share. Shares of WEN are now starting to spike higher and move within range of triggering a major breakout trade above the upper-end of its recent range.

  Market players should now look for long-biased trades in WEN if it manages to break out above its 52-week high at $8.88 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 6.61 million shares. If that breakout hits soon, then WEN will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets of that breakout are $12 to $15 a share.

  Traders can look to buy WEN off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $8.23 a share, or below more support at $8.11 a share. One can also buy WEN off strength once it clears its 52-week high at $8.88 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Emily Jane Fox]

  In the past year, millennials turned up the heat against low wages at Victoria's Secret, Wal-Mart (WMT, Fortune 500), McDonald's (MCD, Fortune 500), Wendy's (WEN), KFC (YUM, Fortune 500) and others like Kaplan (GHC), which runs tutoring centers.

• [By Rick Munarriz]

  The same article singles out a QSR study that showed that the average customer had to wait 188.8 seconds at the chain's drive-thru, nearly a minute more than rival Wendy's (NASDAQ: WEN  ) .

• [By Ben Levisohn]

  Shares of McDonald’s have dropped 1.7% to $95.95 at 1:16 p.m., while Wendy’s�(WEN) has risen 0.5% to $8.30 and Burger King Worldwide (BKW) has advanced 1.2% to $25.44.

10 Best Cheap Stocks To Invest In 2014: Whole Foods Market Inc.(WFM)

Whole Foods Market, Inc. engages in the ownership and operation of natural and organic food supermarkets. The company offers produce, seafood, grocery, meat and poultry, bakery, prepared foods and catering, coffee and tea, nutritional supplements, and vitamins. It also provides specialty products, such as beer, wine, and cheese; body care and educational products, such as books; and floral, pet, and household products. As of February 9, 2011, the company operated 302 stores in the United States, Canada, and the United Kingdom. Whole Foods Market, Inc. was founded in 1978 and is headquartered in Austin, Texas.

Advisors' Opinion:

• [By Lauren Pollock]

  Whole Foods Market Inc.'s(WFM) fiscal fourth-quarter earnings rose 7.1% as the high-end supermarket chain continued to record sales growth. However, shares fell 9.2% to $58.56 in premarket trading as results missed expectations and the company cut its fiscal year guidance, citing current sales trends.

• [By James E. Brumley]

  Quick, what do Wal-Mart Stores, Inc. (NYSE:WMT), Whole Foods Market, Inc. (NASDAQ:WFM), and Jamba, Inc. (NASDAQ:JMBA) - the purveyor of Jamba Juice smoothie shops - have in common? They're all three offering at least one product from KonaRed Corp. (OTCBB:KRED). All told, KRED products can be found in a variety of retail outlets, ranging from mass marketers like WMT to niche players like WFM to service providers like JMBA to convenience stores like 7-Eleven to grocers like Albertson's to.... well, the point becomes clear. KonaRed is in a lot of places. Yet, the number of spots where a KRED could multiply by eight by the middle of the year. In fact, the organization's growth rate is the most exciting - and perhaps most understated - aspect of the KonaRed story.

Facebook Keeps Earnings Growth Coming, Share Price Follows

Facebook Inc. (NASDAQ: FB) released its third-quarter 2013 earnings report after markets closed on Wednesday. Sales rose by 60% year over year to $2.02 billion in the quarter. Adjusted earnings came in at $0.25 per share, versus $0.12 per share a year ago. Thomson Reuters was calling for the report to be $0.19 per share earnings and $1.91 billion in revenues.

Facebook investors are liking what they see this afternoon. We have broken out the main metrics that will drive most of the conversation on Thursday. The highlights are continued user growth, mobile ad growth, total revenue and income growth, solid cash balances, and more. Here are some highlights:

The non-GAAP operating margin rose sequentially from 44% to 49% and from 42% in the same period a year ago. Revenue from advertising totaled $1.80 billion, which is 89% of total revenue and is 66% higher than a year ago. Mobile advertising revenue was roughly 49% of advertising revenue for the third quarter, up sequentially from 41%. Payments and other fees revenue was $218 million for the quarter. Cash and marketable securities totaled $9.3 billion at the end of the quarter. Daily active users were 728 million on average in September. Monthly active users rose to 1.19 billion in the quarter, up 18% from a year earlier. Mobile monthly average users were up 45% to 874 million, while mobile daily average users were 507 million for September. Excluding share-based compensation and related payroll tax expenses, its expenses were up 45% from a year ago to $1.28 billion.

Top 5 Supermarket Stocks To Buy Right Now

The fact that mobile advertising now accounts for essentially half of Facebook's ad revenues is really the remarkable figure here. That and the fact that 728 million people a day look at their Facebook page.

Facebook's shares closed down 0.8% at $49.01 on Wednesday, against a 52-week trading range of $18.87 to $54.83. The reaction in the after-hours has shares up more than 11% at $54.59. Thomson Reuters had a consensus price target of about $54.60 before today's results.

Best Biotech Companies To Watch In Right Now

Popular Posts: 7 Biotechnology Stocks to Buy Now18 Oil and Gas Stocks to Sell Now4 Semiconductor Stocks to Buy Now Recent Posts: 5 Stocks With Great Earnings Growth ��MIL MA MXWL INOC AEGN 5 Worst Sectors to Avoid This Week 5 Stocks With Poor Earnings Growth ��KWK GNK SOL CRK LM View All Posts

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

MFC Industrial () sources and delivers commodities and materials throughout the world. MIL also gets A’s in Earnings Momentum, Cash Flow and Operating Margin Growth. .

Top 5 Net Payout Yield Stocks For 2015: GW Pharmaceuticals PLC (GWPRF)

GW Pharmaceuticals plc is a United Kingdom-based company. The Company is engaged in the research, development and commercialization of a range of cannabinoid prescription medicines to meet patient needs in a range of medical conditions. The Company is developing a portfolio of cannabinoid medicines, of which the main product is Sativex, an oromucosal spray for the treatment of Multiple Sclerosis (MS) symptoms, cancer pain and neuropathic pain. The Company operates in three segments: Sativex Commercial, Sativex Research and Development and Pipeline Research and Development. The Company�� wholly owned subsidiaries include GW Pharma Limited, G-Pharm Limited, Cannabinoid Research Institute Limited, Guernsey Pharmaceuticals Limited and GWP Trustee Company Limited. Advisors' Opinion:

• [By Ben Levisohn]

  But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).

Best Biotech Companies To Watch In Right Now: Applied Nanotech Holdings Inc (APNT)

Applied Nanotech Holdings, Inc., incorporated on May 22, 1989, is engaged in nanotechnology research and development business. The Company's nanotechnology research involves performing contract research and development services for others to develop products and materials for new applications, and then leveraging this research by applying it to other similar applications in other industries. The Company also develops intellectual property (IP) around its products and technologies. The Company develops five technology platforms: nanosensor technology; nanocomposites, based on carbon nanotube composites; thermal management materials; nanoelectronics applications, and electron emission activities, primarily in the display area. The Company's electron emission IP is divided into display activities and non-display activities. Applied Nanotech Holdings, Inc. is the parent company. Applied Nanotech, Inc. (ANI) is a subsidiary of ANHI. During the year ended December 31, 2012, the Company formed EZDiagnostix, Inc., (EZDX).

Sensors

The Company develops sensors based on ion mobility sensor technology and differential mobility spectroscopy. The Company is involved in projects to develop Mercaptan and Methane sensors for uses in the natural gas industry. The Company is also applying this technology to other applications, including agricultural pathology, wound care, and breath analysis. The Company develops hydrogen sensor for use in the measurement of hydrogen in power transformer products. The Company develops carbon monoxide sensor that can last for 10,000 hours on a single battery. The Company's carbon nanotube technology is for use in biosensors. Sensors based on carbon nanotubes or other nanomaterials can be used to detect chemical, organic, or biological warfare agents, as well as explosives, hydrogen, ammonia and numerous other chemicals.

Nanocomposites

The Company is in the advanced stages of development of nanomaterials using carbon nanotube (CNT) and! other composites. Epoxies are used in industries with worldwide markets, with applications, including adhesives, paints, coatings, and composites. In addition to epoxy resins, the Company develops other types of resins, including polyesters and vinyl esters. Vinyl esters are used in a variety of industrial applications, including storage tanks, piping, and construction. The Company develops a process for coating nylon pellets with CNTs to improves electrical conductivity. Nylon 6 with improved electrical conductivity can be used for its anti-static qualities, electrostatic discharge, and electromagnetic/RF shielding.

Thermal Management

The Company markets thermal management material called CarbAl. CarbAl provides a passive thermal management solution for temperature control issues that plague electronics manufacturers. CarbAl is a carbon based metal nanocomposite comprised of 80% carbonaceous matrix and a dispersed metal component of 20% aluminum. The Company also develops a simplified version of CarbAl based on graphite.

Conductive Inks

The Company develops aluminum and silver inks and pastes that is ideal for use in the production of solar cells. The Company also develops aluminum paste that can be used in current solar cell production.

The Company competes with Zyvex Performance Materials, GSI Creos, Amroy Europe, Ltd., DuPont and Ferro

Advisors' Opinion:

• [By Anuchit Nguyen]

  India�� S&P BSE Sensex rose, holding at a three-year high, amid better-than-estimated corporate earnings. Engineering company Larsen & Toubro Ltd. (LT) rallied to a three-month high and Asian Paints Ltd. (APNT) surged about 6 percent after reporting profit that beat forecasts.

Best Biotech Companies To Watch In Right Now: Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes-protease (partnered with AbbVie, the former research-based pharmaceutical business of Abbott Laboratories), NS5A (partnered with Novartis) and nucleotide polymerase, as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. ABT-450, discovered through its collaboration with AbbVie, is a protease inhibitor that has demonstrated in vitro potency against known resistant HCV mutants.

In Phase I studies, ABT-450 co-administered with ritonavir, a commonly used boosting agent to increase the blood concentrations of many protease inhibitors, was shown to be safe and well tolerated. Co-administration of ABT-450 with ritonavir, which it refers to together as ABT-450/r, has enabled once-daily dosing of ABT-450. Phase II studies have demonstrated the efficacy of ABT-450/r in patients with chronic HCV, and other interferon-free Phase II studies of ABT-450-containing regimens continue. AbbVie is developing a next-generation protease inhibitor discovered within the Enanta-AbbVie collaboration. EDP-239 is the NS5A inhibitor discovered by the Company. The Company also has a program to develop nucleotide inhibitors to HCV NS5B polymerase, which is another DAA mechanism considered to have a barrier to resistance. The Company�� Bicyclolide antibiotic product candidate is EDP-788, which it is developing for use as an intravenous drug in the hospital setting and for oral dosing in the home setting. EDP-788 is a prodrug, which means that it is inactive until it is converted in the body into an active compound. EDP-788 is! a water-soluble molecule which, when administered in preclinical models, is cleanly and rapidly converted into the active compound.

Advisors' Opinion:

• [By James Fink]

  And lastly I'll go into healthcare, which is kind of a growth cyclical type name. It's partially defensive, partially growth. I think the more growth-oriented section of healthcare would be biotech, and right now, a very promising biotech stock is Enanta Pharmaceuticals. That's a NASDAQ stock; ticker symbol (ENTA).

• [By George Budwell]

  Normally, such strong efficacy results would be hailed as a major achievement. However, these results are actually less impressive than those by competing drug's developed by AbbVie (NYSE: ABBV  ) , Enanta Pharmaceuticals (NASDAQ: ENTA  ) and Gilead. Bristol-Myers' therapy also has a treatment duration double that of Gilead's drug Sovaldi for genotype 1 patients. So, while these results are impressive in their own right, the therapy's commercial prospects may be limited due to the presence of superior competitors in the market.�

Best Biotech Companies To Watch In Right Now: Gentium SpA(GENT)

Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of its primary product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded DNA extracted from pig intestines. It develops defibrotide for the treatment and prevention of hepatic veno-occlusive disease (VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The company has completed a Phase III clinical trial of defibrotide for the treatment of severe VOD in the United States, Canada, and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD. It also offers sulglicotide that is developed from swine duodenum, and has ulcer healing and gastrointestinal protective properties in South Korea; and urokinase, which is made from human urine to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms. The company was formerly known as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in July 2001. Gentium S.p.A. was founded in 1993 and is headquartered in Villa Guardia, Italy.

Advisors' Opinion:

• [By James Oberweis]

  Gentium Spa (GENT) is focused on the development and commercialization of its leading product, defibrotide, to treat certain complications arising from chemotherapy, and bone marrow and stem cell transplantation therapy.

• [By Sean Williams]

  A parabolic problem
  It has also been a year to remember for shareholders of biopharmaceutical company Gentium (NASDAQ: GENT  ) whose share price has catapulted approximately 600% off its lows thanks to growth in its lead drug Defibrotide (known as Defitelio in the European Union).

Best Biotech Companies To Watch In Right Now: Celgene Corp (CELG)

Celgene Corporation is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. The Company is engaged in the research and development, which is designed to bring new therapies to market, and is engaged in research in several scientific areas that may deliver therapies, focusing areas, such as intracellular signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases, and therapeutic application of cell therapies. The Company�� primary commercial stage products include REVLIMID, VIDAZA, THALOMID, ABRAXANE and ISTODAX. Additional sources of revenue include a licensing agreement with Novartis, which entitles it to royalties on FOCALIN XR and the entire RITALIN family of drugs, the sale of services through its Cellular Therapeutics subsidiary and other miscellaneous licensing agreements. In March 2012, it acquired Avila Therapeutics.

The Company invests in research and development, and the drug candidates in its pipeline at various stages of preclinical and clinical development. These candidates include pomalidomide and apremilast, its oral anti-cancer and anti-inflammatory agents, PDA-001, its cellular therapy, oral azacitidine, CC-223 and CC-115 for hematological and solid tumor malignancies, CC-122, its anti-cancer pleiotropic pathway modifier, and ACE-011 and ACE-536 biological products for anemia in several clinical settings of unmet need. Celgene product candidates include Pomalidomide (CC-4047), Oral Anti-Inflammatory: Apremilast (CC-10004), CC-11050, Kinase Inhibitors:Tanzisertib (CC-930), Cellular Therapies: PDA-001, Activin Biology: Sotatercept (ACE-011) ACE-536, and Anti-tumor Agents: CC-22, CC-115, CC-122 and Oral Azacitidine. It owns and operates a manufacturing facility in Zofingen, Switzerland. The Company also owns and operates a drug product manufacturing facility in Boudry, Switzerland.

Commercial! Stage Products

REVLIMID (lenalidomide) is an oral immunomodulatory drug marketed in the United States and many international markets, in combination with dexamethasone, for treatment of patients with multiple myeloma who have received at least one prior therapy. It is also marketed in the United States and certain international markets for the treatment of transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. REVLIMID is distributed in the United States through contracted pharmacies under the RevAssist program, which is a risk-management distribution program. Internationally, REVLIMID is distributed under mandatory risk-management distribution programs.

REVLIMID continues to be evaluated in numerous clinical trials worldwide either alone or in combination with one or more other therapies in the treatment of a range of hematological malignancies, including multiple myeloma (MDS) various lymphomas, chronic lymphocytic leukemia (CLL) other cancers and other diseases. VIDAZA (azacitidine for injection) is a pyrimidine nucleoside. VIDAZA is a Category 1 recommended treatment for patients with intermediate-2 and high-risk MDS and is marketed in the United States for the treatment of all subtypes of MDS. In Europe, VIDAZA is marketed for the treatment of intermediate-2 and high-risk MDS, as well as acute myeloid leukemia (AML) with 30% blasts and has been granted orphan drug designation for the treatment of MDS and AML.

THALOMID (thalidomide) is marketed for patients with newly diagnosed multiple myeloma and for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) an inflammatory complication of leprosy and as maintenance therapy for prevention and suppression of the cutaneous manifestation of ENL recurrence. THALOMID is distributed in the United States under its System f! or Thalid! omide Education and Prescribing Safety (S.T.E.P.S.) program. Internationally, THALOMID is also distributed under mandatory risk-management distribution programs. ABRAXANE (paclitaxel albumin-bound particles for injectable suspension) is a solvent-free chemotherapy treatment option for metastatic breast cancer, which was developed using its nab technology platform. This protein-bound chemotherapy agent combines paclitaxel with albumin. As of December 31, 2011, ABRAXANE was in various stages of investigation for the treatment of expanded applications for metastatic breast; non-small cell lung; malignant melanoma; pancreatic; bladder and ovarian.

ISTODAX (romidepsin) has received orphan drug designation for the treatment of non-Hodgkin's T-cell lymphomas, which includes CTCL and PTCL. The Company has licensed the worldwide rights (excluding Canada) regarding certain chirally pure forms of methylphenidate for FOCALIN and FOCALIN XR to Novartis. It also licensed to Novartis the rights related to long-acting formulations of methylphenidate and dex-methylphenidate products which are used in FOCALIN XR and RITALIN LA.

Preclinical and Clinical-Stage Pipeline

The product candidates in the Company�� pipeline are at various stages of preclinical and clinical development. Pomalidomide is a small molecule that is orally available and modulates the immune system and other biologically important targets. Pomalidomide is being evaluated in a phase III clinical trial for the treatment of myelofibrosis and a phase III clinical trial evaluating pomalidomide as a treatment for patients with relapsed/refractory multiple myeloma is accruing patients.

The Company is developing a product, ORAL ANTI-INFLAMMATORY AGENTS, which is orally available small molecules that target PDE4, an intracellular enzyme that modulates the production of multiple pro-inflammatory and anti-inflammatory mediators, including interleukin-2 (IL-2), IL-10, IL-12, IL-23, INF-gamma, TNF-a, leukotrienes,! and nitr! ic oxide synthase. Its investigational drug, apremilast (CC-10004), is used for the treatment of moderate to severe psoriasis and active psoriatic arthritis and is being evaluated in a phase II trial for rheumatoid arthritis and six phase III multi-center international clinical trials. In addition, it is investigating its oral PDE4 inhibitor, CC-11050, which is an anti-inflammatory compound that treat a variety of chronic inflammatory conditions, such as Cutaneous Lupus Erythematosus (CLE).

The Company�� oral kinase inhibitor platform includes inhibitors of the c-Jun N-terminal kinase (JNK) mTOR kinase, spleen tyrosine kinase (Syk) c-fms tyrosine kinase (c-FMS) and DNA-dependent protein kinase (DNAPK). Its oral Syk, c-FMS and DNAPK kinase inhibitors are being investigated in pre-clinical studies. The Company�� new second generation JNK inhibitor, tanzisertib (CC-930), is being evaluated in a phase II trial for the treatment of idiopathic pulmonary fibrosis and a phase II trial for the treatment of discoid lupus is accruing patients. Amrubicin is a third-generation fully synthetic anthracycline molecule with potent topoisomerase II inhibition.

At Celgene Cellular Therapeutics (CCT), it is researching stem cells derived from the human placenta, as well as from the umbilical cord. CCT is the Company�� research and development division. Stem cell based therapies provide disease-modifying outcomes for serious diseases, which lack adequate therapy. It has developed technology for collecting, processing and storing placental stem cells with broad therapeutic applications in cancer, auto-immune diseases, including Crohn's disease, multiple sclerosis, neurological disorders, including stroke and amyotrophic lateral sclerosis (ALS), graft-versus-host disease, and other immunological / anti-inflammatory, rheumatologic and bone disorders.

The Company has collaborated with Acceleron Pharma, Inc. (Acceleron) to develop sotatercept. Two phase I clinical studies have been co! mpleted. ! An additional phase II clinical study has been initiated and is ongoing related to treatments for end-stage renal anemia and to evaluate effects on red blood cell mass and plasma volume.

The Company competes with Abbott Laboratories, Amgen Inc. (Amgen), AstraZeneca PLC., Biogen Idec Inc., Bristol-Myers Squibb Co., Eisai Co., Ltd., F. Hoffmann-LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Pfizer, Sanofi and Takeda Pharmaceutical Co. Ltd. (Takeda).

Advisors' Opinion:

• [By Ben Levisohn]

  JPMorgan changed its ratings on Biogen Idec (BIIB) and Celgene (CELG) today, with the former going up, and the latter coming down.

  JPMorgan’s Geoff Meacham and team explain why they upgraded Biogen Idec to Overweight from Neutral…

• [By Ben Levisohn]

  That would be Amgen (AMGN), which fell 1.4% today,� Biogen Idec (BIIB), which dropped 5.1%, Celgene�(CELG), which declined 2.1%, Gilead Sciences (GILD), which dropped 4%, Regeneron Pharmaceuticals (REGN), which fell 3.8%, and Alexion Pharmaceuticals (ALXN), which finished off 1.1%.

• [By Ben Levisohn]

  Shares of Gilead (GILD) and Celgene (CELG) have tumbled today after both companies revealed that they were facing patent pressures.

  For Gilead, Idenix Pharmaceuticals (IDIX) filed a patent-infringement lawsuit that appears to target Gilead’s Sovaldi (someone please correct me if I’m wrong). For Celgene, it was the decision of a New Jersey court to schedule a hearing on a patent case for April 29, earlier than expected. It hasn’t helped that the UK’s National Institute for Health and Care Excellence also said that Celgene’s Revlimid doesn’t work well enough to be covered for “second line treatment of multiple myeloma.”

• [By Ben Levisohn]

  Werber also thinks Alexion Pharmaceuticals (ALXN), Amgen (AMGN),
  Biogen Idec (BIIB), Celgene (CELG) and Regeneron (REGN) will beat earnings.

  Gilead Sciences has gained 1% to $87.96 at 12:36 p.m. today, while Alexion Pharmaceuticals has risen 0.4% to $164.93, Amgen has advanced 1.2% to $122.48, Biogen has ticked up 0.3% to $331.90 and Regeneron has jumped 1.3% to $312.49. Celgene is little changed at $90.10.

Top Retail Companies To Watch For 2014

Charles Schwab’s second quarter ETF Investor Snapshot, released Tuesday, reported that exchange-traded-fund assets custodied at the firm at the end of June reached $217 billion, a 30% increase over June 2013.

According to the report, second quarter ETF flows amounted to $5.2 billion, up 9% from the first quarter.

Equity funds represented 70% of the flows, well up from 25% in the first three months of the year. Of this, 39% went to U.S. equity and 31% to international equity.

Fixed income accounted for just 4% of ETF flows in the second quarter, a big drop from the previous quarter, which the report ascribed to large outflows from short-term bond funds.

The ETF Investor Shapshot is based on analysis of ETFs on the Charles Schwab platform, regardless of ETF or distributor.

The report said retail traders enrolled in Schwab Trading Services captured 11% of the ETF flows in the July 2013 to June 2014 period, up from just 6% in the previous year.

Top 5 Electric Utility Stocks To Invest In Right Now: CarMax Inc(KMX)

CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States. It also sells vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions, as well as sells new vehicles under franchise agreements. In addition, the company provides customers financing alternatives through its finance operation, CarMax Auto Finance, as well as through its third-party financing providers. Further, it offers a range of other related products and services, including the sale of extended service plans, guaranteed asset protection, and accessories; the appraisal and purchase of vehicles directly from consumers; and vehicle repair services. As of December 21, 2011, the company operated 107 used car superstores in 52 markets. CarMax, Inc. was founded in 1993 and is headquartered in Richmond, Virginia.

Advisors' Opinion:

• [By Rick Aristotle Munarriz]

  M. Spencer Green/AP CarMax (KMX) reported quarterly results last week. The market didn't like it. Shares of the leading used-car dealer fell by 4 percent on Friday, carrying over into another 4 percent loss on Monday. It wasn't a bad report -- Wall Street was just holding out for a better overall performance as sales and earnings fell short of expectations. CarMax's report offers a great glimpse into trends of the resale market, which tops the 16 million or so new cars sold every year. Let's go over a few things that CarMax was taught us this time around. CarMax's Model is Gaining Popularity Used-car salesmen used to have a shady reputation, but today's youth will probably have to stream a copy of "Used Cars," a 1980 film with Kurt Russell, to get that feeling. No longer do we automatically think of slick-talking salesmen trying to unload lemons. CarMax offers an experience that's a lot closer to new car showrooms with clean floors, massive selection and sales reps that don't necessarily have a hidden agenda because the cars are sold at haggle-free prices. What you see is what you will pay. Potential car buyers seem to like it that way. CarMax claims that its market share has risen by 17 percent over the past year in terms of its core product of selling cars that are no more than 10 years old. Folks Prefer Newer Used Cars The economy's improving, but that doesn't mean that everyone can afford a new car. In fact, CarMax posted its best store-level comps growth in terms of the number of vehicles sold at its lots since 2002. It sold 12 percent more used cars at the individual store level last year than it did in 2012. However, these folks still don't want to drive really old cars. CarMax revealed during its conference call that 70 percent of its sales are for vehicles that are 4 years old or newer. It's Getting Hard for Drivers with Bad Credit to Get the Keys One of the negative surprises in CarMax's report is that the number of car sales going through t

Top Retail Companies To Watch For 2014: WH Smith PLC (SMWH)

WH Smith PLC is a United Kingdom-based retail company. The Company has two businesses divisions: Travel and High Street. The Company's Travel division sells a range of newspapers, magazines, books and impulse products for people on the move and a broader convenience range in hospitals and workplaces. The Company's High Street sells a wide range of stationery, books, newspapers, magazines and impulse products, as well as a small range of entertainment products.The Company�� subsidiaries include WH Smith PLC, WH Smith Retail Holdings Limited, WH Smith High Street Holdings Limited, WH Smith Travel Holdings Limited, WH Smith High Street Limited, WH Smith Travel Limited and WH Smith Hospitals Holdings Limited. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Hays Plc (HAS) climbed 2.2 percent after the recruitment company said quarterly fees increased in its European markets. WH Smith Plc (SMWH) jumped the most in six months after raising its final dividend and saying it plans to repurchase an additional 50 million pounds ($80 million) of shares. Melrose Industries Plc (MRO) added 1.8 percent after KKR & Co. said it will pay about $1 billion for two of its U.S. industrial-products companies.

Top Retail Companies To Watch For 2014: Burberry Group PLC (BRBY)

Burberry Group plc (Burberry) is a holding company. The Company designs and sources luxury apparel and accessories, selling through a diversified network of retail (including digital), wholesale and licensing channels worldwide. The Company�� Retail/wholesale channel is engaged in the sale of luxury goods through Burberry mainline stores, concessions, outlets and digital commerce, as well as Burberry franchisees, prestige department stores globally and multi-brand specialty accounts. The Company�� retail channel includes approximately 206 mainline stores, 214 concessions within department stores, digital commerce and 49 outlets. The Company�� wholesale channel includes sales to department stores, multi-brand specialty accounts, Travel Retail and franchisees who operates approximately 65 Burberry stores. Advisors' Opinion:

• [By Alexis Xydias]

  Prudential Plc, Britain�� biggest insurer by market value, climbed 1.6 percent after saying nine-month sales rose 6 percent. Burberry (BRBY) Group Plc rose 0.6 percent after reporting first-half earnings.

• [By Jonathan Morgan]

  Burberry (BRBY) added 1.8 percent to 1,488 pence. Revenue climbed 17 percent to 1.03 billion pounds, while adjusted pretax profit for the six months ended Sept. 30 rose to 174 million pounds from 173 million pounds a year earlier, the London-based trenchcoat maker said in a statement.

• [By Sarah Jones]

  Burberry Group Plc (BRBY) climbed 1.4 percent to 1,299 pence. Goldman Sachs also added the U.K.�� largest luxury-goods maker to its conviction buy list. The brokerage said that Burberry�� fundamentals remain robust.

• [By Sofia Horta e Costa]

  Commodity producers slid as the release fueled concern about the slowdown in the world�� second-biggest economy. Burberry Group Plc (BRBY) gained 4.8 percent after the company�� spring-summer collection helped increase retail sales in its fiscal first quarter by more than analysts had estimated. Tryg A/S (TRYG) added 3.3 percent after posting better-than-forecast pretax profit as cost cuts offset increased weather-related claims.

Top Retail Companies To Watch For 2014: Susser Holdings Corporation(SUSS)

Susser Holdings Corporation, together with its subsidiaries, operates convenience stores in Texas, New Mexico, and Oklahoma. The company operates in two segments, Retail and Wholesale. The Retail segment operates convenience stores that offer merchandise, food service, and motor fuel, as well as provides other services, including car washes, lottery, ATM, money orders, prepaid phone cards and wireless services, and movie rentals. As of January 1, 2012, it operated 541 convenience stores under the Stripes brand name. The Wholesale segment distributes motor fuel to its retail convenience stores, contracted independent operators of convenience stores, unbranded convenience stores, unattended fueling facilities, and other end users in Texas, New Mexico, Oklahoma, and Louisiana. The company also offers environmental, maintenance, and construction management services to the petroleum industry; and sells and installs motor fuel dispensers and tanks, as well as provides a range of environmental consulting services, such as hydrocarbon remediation, and Phase I and II site assessments for its stores and outside customers. Susser Holdings Corporation is based in Corpus Christi, Texas.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  Susser Holdings (NYSE: SUSS) shares shot up 35.74 percent to $77.41 after Energy Transfer Partners LP (NYSE: ETP) announced its plans to acquire Susser Holdings in a deal valued at around $1.8 billion.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Susser Holdings (NYSE: SUSS  ) , whose recent revenue and earnings are plotted below.

Top Retail Companies To Watch For 2014: GUESS? Inc (GES)

Guess?, Inc. (GUESS?) designs, markets, distributes and licenses apparel and accessories for men, women and children. The Company operates in five: Europe, North American Retail, Asia, North American Wholesale and Licensing. The Company�� products are sold through retail, wholesale, e-commerce and licensing distribution channels. The lines include full collections of clothing, including jeans, pants, skirts, dresses, shorts, blouses, shirts, jackets, knitwear and intimate apparel. It also grant licenses to manufactures and distributes a range of products, including eyewear, watches, handbags, footwear, kids' and infants' apparel, leather apparel, swimwear, fragrance, jewelry and other fashion accessories. In fiscal 2012, the Company, along with its distributors and licensees, opened 224 stores in all concepts combined outside of the United Sates and Canada, which consisted of 120 stores in Europe and the Middle East, 89 stores in Asia and 15 stores in the combined area of Central and South America.

As of January 28, 2012, the Company directly operated a total of 504 stores in the United Sates and Canada and 251 stores outside of the United Sates and Canada, and in addition, 230 smaller-sized concessions in Asia and Europe. As of January 28, 2012, its international licensees and distributors operated 804 stores located outside the United Sates and Canada, and 119 smaller-sized licensee operated concessions located in Asia. As of January 28, 2012, it operated retail Websites in the United Sates, Canada, Europe and South Korea. As of January 28, 2012, it had e-commerce available to 26 countries, and in 6 languages around the world. The Company and its network of licensee partners sell its products around the world primarily through six different store concepts, namely its flagship GUESS? retail stores, its GUESS? factory outlet stores, its GUESS by MARCIANO stores, its G by GUESS stores, its GUESS? Accessories stores and its GUESS? Kids stores. The Company also has a small number of footwe! ar, Gc watch and underwear concept stores.

Europe Segment

In the Company�� Europe segment, GUESS? sells its products in 63 countries throughout Europe and the Middle East through wholesale, retail and e-commerce channels. In fiscal 2012, its Europe segment accounted for approximately 37.6% of its revenues. The Company�� European wholesale business generally relies on a large number of smaller regional distributors and agents to distribute its products primarily to smaller independent multi-brand boutiques. The Company�� products are also sold directly to department stores like Galeries Lafayette, Printemps and El Corte Ingles. As of January 28, 2012, GUESS? had showrooms in Barcelona, Dusseldorf, Munich, London, Paris, Florence and Lugano. It sells both its apparel and certain accessories products under the Company�� GUESS? and GUESS by MARCIANO brand concepts through its wholesale channel, operating primarily through two seasons, Spring/Summer and Fall/Winter.

The Company�� European retail network consists of a mix of directly operated and licensee operated GUESS? and GUESS by MARCIANO retail and outlet stores, GUESS? Accessories stores, GUESS? Footwear stores and GUESS? Kids stores. As of January 28, 2012, it had 179 directly operated stores and 382 licensee stores, excluding 17 smaller-sized concessions in Europe. During fiscal 2012, the Company opened 45 new directly operated stores, 75 licensee stores and 5 concessions. The Company�� GUESS? Accessories stores average approximately 800 square feet, GUESS by MARCIANO stores average approximately 1,300 square feet and full-price GUESS? stores generally average 2,300 square feet.

North American Retail Segment

In the Company�� North American Retail segment, it sells its products through a network of directly operated retail and factory outlet stores in North America and through its on-line stores. In fiscal 2012, the Company�� North American Retail segment accounted for ap! proximate! ly 41.6% of its revenue. As of January 28, 2012, it also directly operated 25 GUESS? branded stores in Mexico through a majority-owned joint venture. The Company�� the United Sates and Canada GUESS? retail stores carry an assortment of men's and women's GUESS? merchandise, including most of its licensed product categories. As of January 28, 2012, these stores occupied approximately 1,025,000 square feet and ranged in size from approximately 2,500 to 13,500 square feet, with most stores between 4,000 and 6,000 square feet. In fiscal 2012, it opened nine new retail stores and GUESS? closed four stores.

The Company�� the United Sates and Canada factory outlet stores are located primarily in outlet malls generally operating outside the shopping radius of its wholesale customers and its retail stores. These stores sell selected styles of men's and women's GUESS? apparel and licensed products. As of January 28, 2012, its the United Sates and Canada factory outlet stores occupied approximately 717,000 square feet and ranged in size from approximately 2,000 to 11,000 square feet, with most stores between 4,500 and 6,500 square feet. In fiscal 2012, it opened 10 new factory stores. The Company�� G by GUESS store carries apparel for both men and women and a line of accessories and footwear. As of January 28, 2012, its G by GUESS stores occupied approximately 317,000 square feet and ranged in size from approximately 4,000 to 10,000 square feet, with most stores between 4,000 and 5,500 square feet. In fiscal 2012, the Company opened 12 new G by GUESS stores and it closed three stores.Its GUESS? Accessories store concept sells GUESS? and GUESS by MARCIANO labeled accessory products.

As of January 28, 2012, the Company�� GUESS? Accessories concept stores occupied approximately 122,000 square feet and ranged in size from approximately 1,000 to 4,000 square feet, with most stores between 1,500 and 2,500 square feet. In fiscal 2012, GUESS? opened four new GUESS? Accessories stores and i! t closed ! three stores. The Company�� GUESS by MARCIANO stores in the United Sates and Canada offer a women's collection designed for the stylish, trend-setting woman. As of January 28, 2012, its GUESS by MARCIANO stores occupied approximately 156,000 square feet and ranged in size from approximately 2,000 to 6,500 square feet, with most stores between 2,000 and 3,000 square feet. In fiscal 2012, it opened two new GUESS by MARCIANO stores and the Company closed four stores. The Company�� North American Retail segment also includes its the United Sates and Canada retail Websites, including www.guess.com, www.gbyguess.com, www.guessbymarciano.com, www.guesskids.com, www.guess.ca and www.guessbymarciano.ca. These Websites operates as virtual storefronts that both sell its products and promotes its brands.

Asia Segment

In the Company�� Asia segment, GUESS? sells its products through wholesale, retail and e-commerce channels throughout Asia. In fiscal 2012, its Asia segment accounted for approximately 9.3% of its revenue. Its Asia retail business includes both licensee and the Company operated stores, including GUESS?, G by GUESS, GUESS by MARCIANO, Gc, GUESS? Accessories and GUESS? Underwear stores. During fiscal 2012, it and its partners opened 89 new stores in Asia, as of January 28, 2012, it had 423 stores, 47 of which it operated directly and 376 of which were operated by licensees or distributors. The Company and its partners opened flagship stores in cities, such as Seoul, Shanghai, Hong Kong, Macau, Taipei and Beijing and have partnered with licensees to develop its business in the second tier cities in this region.

North American Wholesale Segment

In the Company�� North American Wholesale segment, it sells its products through wholesale channels in North America and to third party distributors based in Central and South America. In fiscal 2012, its North American Wholesale segment accounted for approximately 7.0% of its revenue. As of January 28, 20! 12, its p! roducts were sold to consumers through 1,005 major doors in the United Sates and Canada. These locations include 345 shop-in-shops, a selling area within a department store that offers an array of its products and incorporates GUESS? signage and fixture designs. The Company has sales representatives in New York, Los Angeles, Toronto, Montreal and Vancouver. During fiscal 2012, Macy's, Inc. was its largest domestic wholesale customer, accounting for approximately 2.7% of its consolidated net revenue.

Licensing Segment

The Company�� licensing segment includes the worldwide licensing operations of the Company. In fiscal 2012, its licensing segment royalties accounted for approximately 4.5% of its revenue. As of January 28, 2012, GUESS? had 19 domestic and international licenses that included eyewear, watches, handbags, footwear, kids' and infants' apparel, leather outerwear, fragrance, jewelry and other fashion accessories; and included licenses for the manufacture of GUESS? branded products in markets, which include Africa, Asia, Australia, Europe, the Middle East, Central America, North America and South America.

Advisors' Opinion:

• [By Monica Gerson]

  Guess? (NYSE: GES) shares fell 5.18% to $27.27 after the company issued downbeat outlook. The retailer projected to post a Q1 loss of $0.05 to $0.09 per share.